These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19145102)

  • 1. Effects of histamine H(3) receptor activation on the behavioral-stimulant effects of methamphetamine and cocaine in mice and squirrel monkeys.
    Banks ML; Manvich DF; Bauzo RM; Howell LL
    Pharmacology; 2009; 83(3):164-9. PubMed ID: 19145102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histamine H3 receptor agonists decrease hypothalamic histamine levels and increase stereotypical biting in mice challenged with methamphetamine.
    Kitanaka J; Kitanaka N; Hall FS; Uhl GR; Tatsuta T; Morita Y; Tanaka K; Nishiyama N; Takemura M
    Neurochem Res; 2011 Oct; 36(10):1824-33. PubMed ID: 21573995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeys.
    Kimmel HL; O'Connor JA; Carroll FI; Howell LL
    Pharmacol Biochem Behav; 2007 Jan; 86(1):45-54. PubMed ID: 17258302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciproxifan, a histamine H₃-receptor antagonist / inverse agonist, modulates methamphetamine-induced sensitization in mice.
    Motawaj M; Arrang JM
    Eur J Neurosci; 2011 Apr; 33(7):1197-204. PubMed ID: 21366724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primates.
    Fantegrossi WE; Bauzo RM; Manvich DM; Morales JC; Votaw JR; Goodman MM; Howell LL
    Psychopharmacology (Berl); 2009 Aug; 205(2):337-47. PubMed ID: 19421742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histamine H(3) receptor ligands modulate L-dopa-evoked behavioral responses and L-dopa derived extracellular dopamine in dopamine-denervated rat striatum.
    Nowak P; Bortel A; Dabrowska J; Biedka I; Slomian G; Roczniak W; Kostrzewa RM; Brus R
    Neurotox Res; 2008; 13(3-4):231-40. PubMed ID: 18522902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge.
    Segal DS; Kuczenski R; O'Neil ML; Melega WP; Cho AK
    Neuropsychopharmacology; 2003 Oct; 28(10):1730-40. PubMed ID: 12865898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
    Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T
    Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus and reinforcing effects of p-fluoro-L-deprenyl in monkeys.
    Yasar S; Gaal J; Justinova Z; Bergman J
    Psychopharmacology (Berl); 2005 Oct; 182(1):95-103. PubMed ID: 15990999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of riluzole and gabapentin on cocaine- and methamphetamine-induced behavioral sensitization in mice.
    Itzhak Y; Martin JL
    Psychopharmacology (Berl); 2000 Aug; 151(2-3):226-33. PubMed ID: 10972469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral effects of cocaine: interactions with D1 dopaminergic antagonists and agonists in mice and squirrel monkeys.
    Katz JL; Kopajtic TA; Myers KA; Mitkus RJ; Chider M
    J Pharmacol Exp Ther; 1999 Oct; 291(1):265-79. PubMed ID: 10490913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sigma1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice.
    Kitanaka J; Kitanaka N; Tatsuta T; Hall FS; Uhl GR; Tanaka K; Nishiyama N; Morita Y; Takemura M
    Psychopharmacology (Berl); 2009 May; 203(4):781-92. PubMed ID: 19052726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between the mGluR2/3 agonist, LY379268, and cocaine on in vivo neurochemistry and behavior in squirrel monkeys.
    Bauzo RM; Kimmel HL; Howell LL
    Pharmacol Biochem Behav; 2009 Nov; 94(1):204-10. PubMed ID: 19703487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of cocaine- and food-maintained behavior by the D2-like receptor partial agonist terguride in squirrel monkeys.
    Platt DM; Rodefer JS; Rowlett JK; Spealman RD
    Psychopharmacology (Berl); 2003 Mar; 166(3):298-305. PubMed ID: 12589523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of haloperidol and SCH 23390 with cocaine and dopamine receptor subtype-selective agonists on schedule-controlled behavior of squirrel monkeys.
    Witkin JM; Schindler CW; Tella SR; Goldberg SR
    Psychopharmacology (Berl); 1991; 104(4):425-31. PubMed ID: 1838199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficits in behavioral sensitization and dopaminergic responses to methamphetamine in adenylyl cyclase 1/8-deficient mice.
    Bosse KE; Charlton JL; Susick LL; Newman B; Eagle AL; Mathews TA; Perrine SA; Conti AC
    J Neurochem; 2015 Dec; 135(6):1218-31. PubMed ID: 26146906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of serotonin 2C receptor agonists on the behavioral and neurochemical effects of cocaine in squirrel monkeys.
    Manvich DF; Kimmel HL; Howell LL
    J Pharmacol Exp Ther; 2012 May; 341(2):424-34. PubMed ID: 22328576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the H3 receptor inverse agonist thioperamide on cocaine-induced locomotion in mice: role of the histaminergic system and potential pharmacokinetic interactions.
    Brabant C; Alleva L; Grisar T; Quertemont E; Lakaye B; Ohtsu H; Lin JS; Jatlow P; Picciotto MR; Tirelli E
    Psychopharmacology (Berl); 2009 Mar; 202(4):673-87. PubMed ID: 18843481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histamine H3 receptor agonist- and antagonist-evoked vacuous chewing movements in 6-OHDA-lesioned rats occurs in an absence of change in microdialysate dopamine levels.
    Nowak P; Dabrowska J; Bortel A; Biedka I; Szczerbak G; Słomian G; Kostrzewa RM; Brus R
    Eur J Pharmacol; 2006 Dec; 552(1-3):46-54. PubMed ID: 17055481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonergic attenuation of the reinforcing and neurochemical effects of cocaine in squirrel monkeys.
    Czoty PW; Ginsburg BC; Howell LL
    J Pharmacol Exp Ther; 2002 Mar; 300(3):831-7. PubMed ID: 11861788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.